annual EBIT:
-$280.56M-$48.74M(-21.02%)Summary
- As of today (May 30, 2025), AXSM annual earnings before interest & taxes is -$280.56 million, with the most recent change of -$48.74 million (-21.02%) on December 31, 2024.
- During the last 3 years, AXSM annual EBIT has fallen by -$155.85 million (-124.98%).
- AXSM annual EBIT is now -15152.91% below its all-time high of -$1.84 million, reached on December 31, 2013.
Performance
AXSM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$56.98M+$15.63M(+21.53%)Summary
- As of today (May 30, 2025), AXSM quarterly earnings before interest & taxes is -$56.98 million, with the most recent change of +$15.63 million (+21.53%) on March 31, 2025.
- Over the past year, AXSM quarterly EBIT has increased by +$10.29 million (+15.30%).
- AXSM quarterly EBIT is now -3258.40% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$270.27M+$10.29M(+3.67%)Summary
- As of today (May 30, 2025), AXSM TTM earnings before interest & taxes is -$270.27 million, with the most recent change of +$10.29 million (+3.67%) on March 31, 2025.
- Over the past year, AXSM TTM EBIT has increased by +$22.46 million (+7.67%).
- AXSM TTM EBIT is now -15829.10% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AXSM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.0% | +15.3% | +7.7% |
| 3 y3 years | -125.0% | -48.8% | -100.0% |
| 5 y5 years | -318.1% | -75.4% | -203.1% |
AXSM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -125.0% | at low | -794.0% | +42.0% | -100.0% | +11.7% |
| 5 y | 5-year | -318.1% | at low | -794.0% | +42.0% | -203.1% | +11.7% |
| alltime | all time | <-9999.0% | at low | -3258.4% | +42.0% | <-9999.0% | +11.7% |
AXSM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$56.98M(-21.5%) | -$270.27M(-3.7%) |
| Dec 2024 | -$280.56M(+21.0%) | -$72.62M(+16.0%) | -$280.56M(-8.4%) |
| Sep 2024 | - | -$62.62M(-19.8%) | -$306.22M(+0.2%) |
| Jun 2024 | - | -$78.05M(+16.0%) | -$305.71M(+4.4%) |
| Mar 2024 | - | -$67.28M(-31.5%) | -$292.73M(+26.3%) |
| Dec 2023 | -$231.82M(+28.9%) | -$98.27M(+58.2%) | -$231.82M(+19.8%) |
| Sep 2023 | - | -$62.12M(-4.5%) | -$193.47M(+11.3%) |
| Jun 2023 | - | -$65.06M(+920.7%) | -$173.76M(+17.5%) |
| Mar 2023 | - | -$6.37M(-89.4%) | -$147.88M(-17.8%) |
| Dec 2022 | -$179.80M(+44.2%) | -$59.92M(+41.3%) | -$179.80M(+17.9%) |
| Sep 2022 | - | -$42.41M(+8.2%) | -$152.49M(+6.3%) |
| Jun 2022 | - | -$39.18M(+2.3%) | -$143.49M(+6.2%) |
| Mar 2022 | - | -$38.29M(+17.4%) | -$135.15M(+8.4%) |
| Dec 2021 | -$124.71M(+24.3%) | -$32.61M(-2.4%) | -$124.71M(+4.1%) |
| Sep 2021 | - | -$33.41M(+8.3%) | -$119.79M(+10.1%) |
| Jun 2021 | - | -$30.85M(+10.8%) | -$108.76M(+13.7%) |
| Mar 2021 | - | -$27.84M(+0.6%) | -$95.69M(-4.6%) |
| Dec 2020 | -$100.33M(+49.5%) | -$27.69M(+23.8%) | -$100.33M(+3.4%) |
| Sep 2020 | - | -$22.37M(+25.8%) | -$97.07M(+3.8%) |
| Jun 2020 | - | -$17.78M(-45.3%) | -$93.51M(+4.9%) |
| Mar 2020 | - | -$32.49M(+33.0%) | -$89.18M(+32.9%) |
| Dec 2019 | -$67.11M | -$24.43M(+29.9%) | -$67.11M(+29.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$18.81M(+39.9%) | -$52.03M(+26.2%) |
| Jun 2019 | - | -$13.45M(+29.0%) | -$41.23M(+15.3%) |
| Mar 2019 | - | -$10.42M(+11.5%) | -$35.77M(+19.9%) |
| Dec 2018 | -$29.84M(+8.1%) | -$9.35M(+16.7%) | -$29.84M(+8.2%) |
| Sep 2018 | - | -$8.01M(+0.3%) | -$27.58M(+7.5%) |
| Jun 2018 | - | -$7.99M(+77.9%) | -$25.66M(+5.1%) |
| Mar 2018 | - | -$4.49M(-36.7%) | -$24.42M(-11.5%) |
| Dec 2017 | -$27.60M(+2.0%) | -$7.09M(+16.4%) | -$27.60M(-0.2%) |
| Sep 2017 | - | -$6.09M(-9.8%) | -$27.66M(-3.9%) |
| Jun 2017 | - | -$6.75M(-12.0%) | -$28.78M(-0.3%) |
| Mar 2017 | - | -$7.67M(+7.3%) | -$28.86M(+6.6%) |
| Dec 2016 | -$27.07M(+135.9%) | -$7.15M(-0.8%) | -$27.07M(+6.8%) |
| Sep 2016 | - | -$7.21M(+5.6%) | -$25.35M(+25.7%) |
| Jun 2016 | - | -$6.83M(+16.1%) | -$20.17M(+30.7%) |
| Mar 2016 | - | -$5.88M(+8.3%) | -$15.42M(+33.5%) |
| Dec 2015 | -$11.47M(+109.1%) | -$5.43M(+168.4%) | -$11.55M(+43.2%) |
| Sep 2015 | - | -$2.02M(-2.9%) | -$8.07M(+4.2%) |
| Jun 2015 | - | -$2.08M(+3.6%) | -$7.74M(+36.9%) |
| Mar 2015 | - | -$2.01M(+3.2%) | -$5.66M(+55.2%) |
| Dec 2014 | -$5.49M(+198.4%) | -$1.95M(+14.8%) | -$3.65M(+114.8%) |
| Sep 2014 | - | -$1.70M | -$1.70M |
| Dec 2013 | -$1.84M | - | - |
FAQ
- What is Axsome Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics annual EBIT year-on-year change?
- What is Axsome Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly EBIT year-on-year change?
- What is Axsome Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics TTM EBIT year-on-year change?
What is Axsome Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AXSM is -$280.56M
What is the all time high annual EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high annual earnings before interest & taxes is -$1.84M
What is Axsome Therapeutics annual EBIT year-on-year change?
Over the past year, AXSM annual earnings before interest & taxes has changed by -$48.74M (-21.02%)
What is Axsome Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AXSM is -$56.98M
What is the all time high quarterly EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly earnings before interest & taxes is -$1.70M
What is Axsome Therapeutics quarterly EBIT year-on-year change?
Over the past year, AXSM quarterly earnings before interest & taxes has changed by +$10.29M (+15.30%)
What is Axsome Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AXSM is -$270.27M
What is the all time high TTM EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM earnings before interest & taxes is -$1.70M
What is Axsome Therapeutics TTM EBIT year-on-year change?
Over the past year, AXSM TTM earnings before interest & taxes has changed by +$22.46M (+7.67%)